The invention relates to complement inhibitors that inhibit both the classicaland alternative complement pathways. In particular, the invention relates tocomplement inhibitors derived from the salivary glands of haematophagousarthropods that inhibit both the classical and alternative complementpathways. The invention also relates to the use of such complement inhibitorsin the treatment and prevention of diseases.